DE2725735A1 - Biologisch aktive peptide - Google Patents

Biologisch aktive peptide

Info

Publication number
DE2725735A1
DE2725735A1 DE19772725735 DE2725735A DE2725735A1 DE 2725735 A1 DE2725735 A1 DE 2725735A1 DE 19772725735 DE19772725735 DE 19772725735 DE 2725735 A DE2725735 A DE 2725735A DE 2725735 A1 DE2725735 A1 DE 2725735A1
Authority
DE
Germany
Prior art keywords
cys
ser
asn
trp
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772725735
Other languages
German (de)
English (en)
Inventor
Marvin Ross Brown
Jean Edouard Frederic P Rivier
Jun Wylie Walker Prof Vale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/785,533 external-priority patent/US4133782A/en
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of DE2725735A1 publication Critical patent/DE2725735A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19772725735 1976-06-07 1977-06-07 Biologisch aktive peptide Withdrawn DE2725735A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69328276A 1976-06-07 1976-06-07
US05/785,533 US4133782A (en) 1976-06-07 1977-04-07 Somatostatin analogs with dissociated biological activities

Publications (1)

Publication Number Publication Date
DE2725735A1 true DE2725735A1 (de) 1977-12-15

Family

ID=27105142

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772725735 Withdrawn DE2725735A1 (de) 1976-06-07 1977-06-07 Biologisch aktive peptide

Country Status (11)

Country Link
JP (1) JPS52156885A (sv)
AU (1) AU509631B2 (sv)
CA (1) CA1102313A (sv)
CH (1) CH640827A5 (sv)
DE (1) DE2725735A1 (sv)
DK (1) DK250977A (sv)
FR (1) FR2375190A1 (sv)
GB (1) GB1567341A (sv)
IL (1) IL52231A (sv)
NL (1) NL7706002A (sv)
SE (1) SE441452B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates

Also Published As

Publication number Publication date
FR2375190A1 (fr) 1978-07-21
FR2375190B1 (sv) 1981-10-30
AU2577577A (en) 1978-12-07
AU509631B2 (en) 1980-05-22
IL52231A (en) 1980-05-30
JPS52156885A (en) 1977-12-27
CH640827A5 (en) 1984-01-31
NL7706002A (nl) 1977-12-09
SE7706567L (sv) 1977-12-08
IL52231A0 (en) 1977-08-31
SE441452B (sv) 1985-10-07
GB1567341A (en) 1980-05-14
DK250977A (da) 1977-12-08
CA1102313A (en) 1981-06-02
JPS6315280B2 (sv) 1988-04-04

Similar Documents

Publication Publication Date Title
DE2813327C2 (sv)
EP0001295B1 (de) Somatostatin-analoge Cyclopeptide, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Anwendung
EP0023192A1 (de) Cyclopeptide und pharmazeutische Präparate davon, sowie Verfahren zu ihrer Herstellung und deren Anwendung
EP0552238A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CH623806A5 (sv)
DE2705514C3 (de) Nonapeptide und diese enthaltende Arzneimittel
EP0083305A1 (de) Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
DE2611779A1 (de) Cyclische undecapeptidanaloge von somatostatin
DE2659758A1 (de) Carba-derivate von somatostatin, verfahren zu ihrer herstellung und arzneimittel
DD153684A5 (de) Verfahren zur herstellung von cyclischen hexapeptid-somatostatin-analogen
EP0075776A1 (de) Bis-thymosin Alpha 1-Verbindungen
DE2734628A1 (de) Fuer die erhoehung der futterausnutzung geeignete cyclische hexapeptide
DE2804566C2 (de) Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3124818A1 (de) Oxytocin-analoga, ihre herstellung und pharmazeutische mittel
DE2725735A1 (de) Biologisch aktive peptide
DD217808A5 (de) Verfahren zur herstellung von saeugetier-pgrf
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
DE2460469A1 (de) Neue peptide mit biologischer wirkung und verfahren zu ihrer herstellung
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
DE2807403C2 (sv)
DE2804567A1 (de) Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2733550A1 (de) Somatostatinanaloga, verfahren zu ihrer herstellung und zwischenprodukte hierfuer
DE3537405A1 (de) Biologisch aktive penta- und heptapeptide, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
EP0054514A1 (de) Neue antibiotisch wirksame Aminopapulacandin-Derivate
DE2749932A1 (de) Verfahren zur herstellung von antidiuretisch wirksamen polypeptiden

Legal Events

Date Code Title Description
8141 Disposal/no request for examination